Research, policy and advocacy

Burnett Foundation Aotearoa works to improve the health and wellbeing of rainbow and takatāpui communities and people living with HIV through research, policy development, advocacy and strategic partnerships.

Alongside our direct services and community programmes, we work to influence the systems, policies and environments that shape people’s lives. This includes supporting research, advocating for evidence-based policy, amplifying community voices, and working with decision-makers to improve health outcomes and reduce inequities.

Our work is informed by science, guided by communities and focused on creating lasting change.

Our focus areas

Our research, policy and advocacy work is focused on improving outcomes in five key areas.

HIV prevention and care

Supporting efforts to eliminate HIV transmission, improve access to prevention tools and treatment, and ensure people living with HIV can live healthy and fulfilling lives.

Rainbow and takatāpui health

Advancing health and wellbeing outcomes for rainbow and takatāpui communities through research, advocacy and evidence-based practice.

Rights, stigma and equity

Reducing HIV-related stigma and discrimination, promoting human rights, and addressing barriers that prevent people from accessing care and support.

Healthcare access and workforce development

Strengthening healthcare systems, improving access to services, and supporting healthcare professionals to provide affirming, evidence-based care.

Community wellbeing

Supporting community-led approaches that strengthen connection, participation and wellbeing.

How we create change

Research

Research helps us understand the experiences, needs and aspirations of the communities we serve.

We conduct, support and contribute to research across our focus areas, while also monitoring the impact of our programmes, campaigns and services. This evidence helps us identify emerging issues, evaluate what works, and ensure our work remains responsive to community needs.

We also work alongside researchers, clinicians and partner organisations throughout Aotearoa New Zealand to strengthen the evidence base for HIV prevention, sexual health, rainbow health and community wellbeing.

Research networks and partners

We work alongside a range of research organisations and networks throughout the motu, including:

Policy

Policy shapes the environments in which people live, access healthcare and experience wellbeing.

We work with government agencies, policymakers, clinicians, and sector partners to ensure policy decisions are informed by evidence, community experience and public health best practice.

This includes contributing to national strategies, policy development, workforce guidance and system improvements that support better outcomes for the communities we serve.

Advocacy

Advocacy has been part of our kaupapa since the beginning of the HIV epidemic.

Since our inception, we have worked alongside communities to challenge inequities, reduce stigma and discrimination, improve access to healthcare, and ensure the voices of people living with HIV and Rainbow communities are heard.

Our advocacy takes many forms, including submissions, public engagement, strategic partnerships, community mobilisation and direct engagement with decision-makers.

Explore recent submissions

We regularly advocate on issues relating to HIV or issues pertinent to our communities through submissions to local councils, government departments, PHARMAC, and Medsafe to name a few. Here are some of our recent submissions:

Big Gay Out Advocacy Brief

Read more

Submission on use of puberty blockers

Read more

Submission on the Principles of the Treaty of Waitangi Bill

Read more

Letter to Police Commissioner on violence against gay men in Christchurch

Read more

Briefing to Minister Doocey on Funded Home Self-Tests for Sexually Transmitted Infections (STI)

Read more

Briefing to Minister Doocey on the Mpox pandemic response

Read more

Briefing to Minister Doocey on Access to HIV Prevention Among Temporary Migrants

Read more

Letter to Minister Reti on Access to HIV Prevention among temporary migrants

Read more

Submission on the Therapeutic Products Bill

Read more

Letter to PHARMAC on national STAT dispensing of antiretroviral treatment

Read more

Feedback to PHARMAC on the proposed changes to funding of emtricitabine with tenofovir disoproxil for preexposure prophylaxis of HIV (PrEP) and antiretrovirals for post-exposure prophylaxis of HIV (PEP)

Read more

Feedback to PHARMAC on the widening of PrEP prescriber eligibility, and proposal of further changes

Read more

Feedback to Medsafe Medicines Classification Committee on the decision to regulate Amyl Nitrates (poppers)

Read more

Submission to Ministry of Health/MBIE Working Group on suggested changes to immigration health requirements for people living with HIV

Read more

Feedback to PHARMAC on the funding of a wider range of funded condoms, and the decision to not have a funded lubricant

Read more

Feedback to PHARMAC on widening eligibility for PEP

Read more

Feedback to PHARMAC on the proposed competing of the INSTI market for the treatment of HIV

Read more

Advice to Medsafe Medicines Classification Committee's 63rd meeting on the regulation of Amyl Nitrates (poppers)

Read more

Application to PHARMAC to fund TAF

Read more

Our impact

Over the years, our advocacy and policy work has contributed to significant changes across Aotearoa. These include:

  • Public funding of PrEP
  • Expanded access to HIV prevention and treatment
  • Wider prescribing eligibility for PrEP, including in pharmacy settings
  • Improved access to funded condoms
  • Changes to immigration policies affecting people living with HIV
  • National strategies and policies supporting HIV prevention and care
  • Greater recognition of HIV-related stigma and discrimination as a public health issue
  • Increased investment in rainbow and takatāpui health initiatives

While significant progress has been made, there is still important work ahead.

PrEP Use and Acceptability

19/12/2022 | Published by Burnett Foundation Aotearoa

Learn more

Enumerating the population eligible for funded HIV pre-exposure prophylaxis (PrEP) in New Zealand

01/02/2019 | Saxton, P. J. W., & McAllister, S. M. Sexual Health, 16 (1), 63-69.


Learn more


Baseline characteristics of gay and bisexual men in a HIV pre-exposure prophylaxis demonstration project with equity quotas in Auckland, New Zealand.

01/02/2019 | Saxton, P. J. W., Azariah, S., Franklin, R. A., Forster, R. F., Werder, S. F., Jenkins, R., Myers, J. Rich, J. Te Wake, Whatitiri P. Fisher, M. D. Sexual Health, 16 (1), 47-55.

Learn more

Baseline characteristics of GBM in a HIV PrEP demonstration project with equity quotas in Auckland

01/10/2018 | Saxton, Peter J., Sunita Azariah, Richard A. Franklin, Rose F. Forster, Suzanne F. Werder, Renee Jenkins, Jason M. Myers, Joseph G. Rich, Whatitiri P. Te Wake and Mark D. Fisher. Sexual Health.

Implementing HIV PrEP: let’s not get caught with our pants down

31/08/2018 | Saxton, Peter J., Massimo Giola, Edward P. Coughlan, Joseph G. Rich, Sunita Azariah, Adrian H. Ludlam, Christy O’Toole, Mike Pohl, Jason M. Myers. NZ Med J 131, no. 1481 (2018).

Learn more

Illicit drug use among New Zealand gay and bisexual men: Prevalence and association with sexual health behaviours

25/04/2017 | Saxton, P., Newcombe, D., Ahmed, A., Dickson, N., & Hughes, A. Drug and Alcohol Review, 37 (2), 180-187.

Learn more

Thirty years of condom-based HIV prevention by gay men in New Zealand

04/12/2015 | Hughes, Anthony J., and Peter J. Saxton. NZ Med J 128, no. 1426 (2015): 2010-2019.

Learn more

HIV prevention today: with coordinated action, we can end transmission

04/12/2015 | Saxton, Peter J., Anthony J. Hughes, and Massimo Giola. NZ Med J 128, no. 1426 (2015): 8-15.

Learn more

GAPSS/GOSS Research Brief: Infrequent condom use between regular male partners

01/03/2015 | Research brief to the Ministry of Health. Saxton P, Dickson N, Hughes A, Ludlam A. The University of Auckland.

Learn more

Snapshots: Gay Auckland Periodic Sex Survey 2014

01/02/2015 | Gay Men’s Sexual Health research group, Dept of Social and Community Health, University of Auckland, 2014.

Learn more

GAPSS/GOSS Research Brief: Infrequent condom use between casual male partners

01/12/2014 | Research brief to the Ministry of Health. Saxton P, Dickson N, Hughes A, Ludlam A. The University of Auckland.

Learn more

Gay Auckland Periodic Sex Survey (GAPSS) and Gay men’s Online Sex Survey (GOSS) 2002-2014

13/11/2014 | Saxton P, Dickson N, Hughes A & Ludlam A. Gay Auckland Periodic Sex Survey (GAPSS) and Gay men’s Online Sex Survey (GOSS): Basic frequency tables 2002-2014. Auckland, NZ: Auckland University 2014

Learn more

Who is Omitted from Repeated Offline HIV Behavioural Surveillance Among MSM?

01/11/2013 | Saxton P, Dickson N, McAllister S, Hughes A. AIDS Behav. 2013;17:2133-3144

Learn more

Characteristics of MSM surveyed in sex-on-site venues in NZ: Findings from the GAPSS and GOSS survey

01/11/2012 | Research brief to the Ministry of Health. Ludlum A, Saxton P, Dickson N, Hughes A. AIDS Epidemiology Group.

Learn more

Actual and undiagnosed HIV prevalence in a community sample of MSM in Auckland, New Zealand

01/03/2012 | Saxton P, Dickson N, Griffiths R, Hughes A, Rowden J. BMC Public Health 2012, 12:92

Learn more

HIV epidemic among gay and bisexual men in New Zealand

01/02/2009 | Saxton P, Hughes A, Keller V. Poster. New Zealand AIDS Foundation.

Learn more

Position statements

Our position statements outline Burnett Foundation Aotearoa's views on key issues affecting people living with HIV and Rainbow and Takatāpui communities.

These documents help guide our advocacy, policy and public engagement work.

Explore our position statements

Testing Position Statement

Updated May 2019

Learn more

Early Treatment Position Statement

Updated May 2019

Learn more

Supplement - National HIV and AIDS Forum Consensus statement on comprehensive HIV prevention in Aotearoa New Zealand

Learn more

Supplement - National HIV and AIDS Forum Position Statement on U=U

Learn more

Pre-Exposure Prophylaxis (PrEP) Position Statement

Updated 2024

Learn more

Condoms Position Statement

Updated 2024

Learn more

Post-exposure prophylaxis (PEP) Position Statement

Updated 2024

Learn more

Get in touch

Strong research, policy and advocacy work is built on community knowledge and participation.

If you have a question, would like to contribute to our work, or would like to discuss an issue affecting your community, we'd love to hear from you.